GlaxoSmithKline Bridges to Access Prescription Assistance Program.

The GlaxoSmithKline Bridges to Access prescription assistance program is being enhanced and expanded in an effort to help even more lower income households. It will also focus on assisting the under insured as well as people that lack any form of medical coverage. The pharmaceutical company has announced that it will be making free prescription medicines easier to obtain for individuals and families that are uninsured, unemployed, or just plain struggling to make ends meet.

On average, the GSK patient assistance program provides discounted or free medicines that are valued at almost $450 million to over 400,000 patients. Most of these beneficiaries either lack the money to buy the drugs they need on their own and/or their insurance does not cover it. Bridges to Access can even be used by households that qualify for Medicaid or Medicare. The medicines were provided in the form of approximately 2.5 million free 30-day prescriptions.

How do I apply?

It is easy to sign up. Currently there are two ways to apply for the Bridges to Access program. There is a self-enrollment option that has a simple, one-page application. Or you can decide to enroll by telephone with the help of a healthcare advocate such as a pharmacist, nurse, doctor, or a social worker. In either case the process is meant to be flexible and give a quick reply to the person seeking help. In the past, all applicants needed to apply through an advocate.

How quickly can I get help?

If you use the self-enrollment form for the GlaxoSmithKline Bridges to Access program, a free 90-day supply of medicine will be mailed to qualified patients within just two days after the receipt of their application (provided they qualify) . Applicants also need to send a request for a prescription and verification of their household income.





However, if you are a patient who needs prescription medicine immediately and can’t wait those two days, then you can enroll by telephone with the help of your advocate. If you use this option, you can immediately pick up a 60-day supply of the medicine you need at any retail pharmacy for just a $10 co-pay. So this second option is even more efficient as all of the application information is communicated over the phone. Remember that most GSK medicines that are used in any outpatient setting are available through the Bridges to Access assistance program.

Patients can receive almost any name-brand or generic drug they need from GSK. Most of the company’s medications that are currently used in an outpatient setting are being provided by Bridges to Access prescription program. Patients can get free prescriptions for diabetic medications such as Avedia and Coreg for heart disease and also the epileptic medication Lamictal among others.

Get details on the GlaxoSmithKline Bridges to Access program.

Like most programs, there are some conditions and criteria to receiving help. Patients who currently get prescription drug benefits from any public or private insurance plan are not eligible for this program. So Glaxo will not overlap with other forms of assistance.

The program will offer free medicines to eligible individuals and families with total household incomes of less than  $27,075 for a single person household; $36,425 for couple; and $55,125 for a household of four. The scale increases even more when their are additional residents in the home. If your income is higher than this, you still can get some aid as patients with incomes above this amount may be able to qualify through an adjustment to their income for certain out-of-pocket medical expenses.

Bridges to Access enrollment applications are available by calling 1-866-PATIENT (1-866-728-4368). If you need more help, GSK offers a number of other resources and programs to help as many patients as possible gain access to the medicines they need. Information on all of the programs available can be found at




Medications paid for by Bridges to Access

The listing below is just a sampling. The list will continue to grow over time, and the sizes may also vary based on exactly what the patient needs.

  • ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder)
  • ADVAIR HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol
  • ANORO ELLIPTA® (umeclidinium and vilanterol inhalation powder)
  • ARNUITY ELLIPTA® (fluticasone furoate inhalation powder)
  • AVANDIA (rosiglitazone maleate) Tablets
  • AVODART (dutasteride) Soft Gelatin Capsules
  • BACTROBAN NASAL OINTMENT (mupirocin calcium ointment, 2%)
  • BECONASE AQ (beclomethasone dipropionate, monohydrate ) Nasal Spray, 0.042%
  • BREO ELLIPTA (fluticasone furoate and vilanterol inhalation powder)
  • COREG CR (carvedilol phosphate extended release capsules)
  • DUAC Topical Gel (clindamycin phosphate 1%, benzoyl peroxide 5%)
  • EPIVIR-HBV (lamivudine) Oral Solution and Tablets
  • FABIOR (tazarotene) Foam
  • FLOVENT HFA 110 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) (fluticasone propionate inhalation powder, 50 mcg)
  • IMITREX (sumatriptan) Nasal Spray
  • INCRUSE ELLIPTA® (umeclidinium inhalation powder)
  • JALYN (dutasteride and tamsulosin hydrochloride) Capsules
  • LAMICTAL (lamotrigine) Starter Kits or Tablets, Chewable Dispersible Tablets or Orally Disintegrating Tablets
  • LAMICTAL XR and ODT (lamotrigine) Patient Titration Kits
  • LOVAZA (omega-3-acid ethyl esters) Capsules
  • MALARONE (atovaquone and proguanil hydrochloride) Tablets
  • MEPRON (atovaquone) Suspension
  • POTIGA (ezogabine) Tablets
  • RELENZA (zanamivir) inhalation powder for oral inhalation
  • REQUIP XL (ropinirole extended-release tablets)
  • RYTHMOL SR (propafenone hydrochloride) extended release Capsules
  • SEREVENT DISKUS (salmeterol xinafoate inhalation powder)
  • SORIATANE (acitretin) Capsules
  • TANZEUM (albiglutide) for injection, for subcutaneous use
  • VENTOLIN HFA (albuterol sulfate HFA inhalation aerosol)
  • VERAMYST (fluticasone furoate) Nasal Spray





What other programs exist from GSK?

Several other programs exist, and they are as follows. Each will have income and other qualifications that need to be met, however they can be combined with Bridges to Access.

The Commitment to Access program for oncology and other specialty pharmacy products. If you are interested in applying for this form of support, low to moderate income patients need to apply with the help of an advocate. There are some conditions, and income eligibility is $54,150 for a household of one; $72,850 for two persons; and $110,250 for a family of four.

GSK Access for Medicare Part D. They are eligible for medicines, and it covers enrollees who have spent at least $600 on prescription medicines this year. Most of this assistance is targeted at senior citizens as well as the disabled. The household income limits for this prescription assistance program are the same as Bridges to Access.

Together Rx Access, which a free prescription medicine savings card program for those who are not eligible for Medicare or other state or federal government programs. This particular program and the discount card was created in 2005 by several pharmaceutical companies, including GSK. In total, Together Rx Access will provide consumers savings on more than 275 products.

To qualify for this, a Together Rx Access participant cannot have current prescription coverage, they can’t be eligible for Medicare, and they also need to be a legal US resident with household income equal to or less than: $30,000 for a single person, $40,000 for a family of two, $50,000 in come for a family of three, $60,000 for a family of four, or $70,000 in income for a family of five. Many clients of are on Medicaid or receive their insurance from the Affordable Care Act (Obamacare). They cal also combine these discounts with free prescriptions from Bridges to Access from Glaxo. For more details on this option, Together Rx Access applications and additional information are available at  1-800-444-4106 or go to


By Jon McNamara

“Related Links” are listed below.




Contact Us

About Us


Privacy policy